Neural Cell News Volume 16.41 | Oct 19 2022

    0
    25








    2022-10-19 | NCN 16.41


    Neural Cell News by STEMCELL Technologies
    Vol. 16.41 – 19 October, 2022
    TOP STORY

    Maturation and Circuit Integration of Transplanted Human Cortical Organoids

    Scientists presented human stem cell-derived cortical organoids transplanted into the somatosensory cortex of newborn athymic rats to develop mature cell types that integrated into sensory and motivation-related circuits.
    [Nature]

    Full ArticlePress Release
    Register for Drug Delivery to the Brain: Challenges and Progress.
    PUBLICATIONSRanked by the impact factor of the journal

    3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells

    To develop in vitro models than can retain cellular features of glioma cells, a 3D-engineered scaffold, fabricated by two-photon polymerization, was developed as a cell culture model system to study patient-derived glioma cells.
    [Small]

    Full Article

    USP36 Promotes Tumorigenesis and Drug Sensitivity of Glioblastoma by Deubiquitinating and Stabilizing ALKBH5

    Investigators elucidated the signaling pathways involved in mediating ALKBH5 protein stability in facilitating the development of glioblastomas.
    [Neuro-Oncology]

    Abstract

    HOXA3 and KDM6A Cooperate in Transcriptional Control of Aerobic Glycolysis and Glioblastoma Progression Get Access Arrow

    Scientists discovered that transcription factor homeobox A3 (HOXA3), which was aberrantly highly expressed in glioblastoma patients, transcriptionally activated aerobic glycolysis, leading to a significant acceleration in cell proliferation and tumor growth.
    [Neuro-Oncology]

    Abstract

    Loss of Non-Motor Kinesin KIF26A Causes Congenital Brain Malformations via Dysregulated Neuronal Migration and Axonal Growth As Well as Apoptosis

    The authors reported a patient cohort with biallelic loss-of-function variants in KIF26A, exhibiting a spectrum of congenital brain malformations.
    [Developmental Cell]

    Full ArticleGraphical Abstract

    Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

    Investigators observed that SOX9, a transcription factor and stem cell/glial fate marker, is limited to rare, quiescent cells in high-risk medulloblastoma with MYC amplification.
    [Cancer Research]

    Abstract
    Full Article

    Druggable Transcriptomic Pathways Revealed in Parkinson’s Patient-Derived Midbrain Neurons

    Scientists identified gene dysregulation of live midbrain neurons reprogrammed in vitro from the skin cells of 42 individuals, including sporadic and familial Parkinson’s disease patients, and matched healthy controls.
    [npj Parkinson’s Disease]

    Full Article

    Combining NGN2 Programming and Dopaminergic Patterning for a Rapid and Efficient Generation of hiPSC-Derived Midbrain Neurons

    Researchers reported developments in combining neurogenin-2 (NGN2) programming with the use of commercially available midbrain differentiation kits for directed differentiation of human-derived induced pluripotent stem cells to mature and functional induced dopaminergic neurons.
    [Scientific Reports]

    Full Article
    Virtual Conference Exhibition: Organoids
    REVIEWS

    Human Cerebral Organoids — a New Tool for Clinical Neurology Research

    Investigators summarize how such organoid models can complement classical approaches to accelerate neurological research.
    [Nature Reviews Neurology]

    Full Article

    CNS Remyelination and Inflammation: From Basic Mechanisms to Therapeutic Opportunities

    The authors review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
    [Neuron]

    Abstract

    INDUSTRY AND POLICY NEWS

    LEXEO Therapeutics Receives Orphan Drug Designation for LX1004 from European Commission

    LEXEO Therapeutics announced that the European Commission has granted orphan drug designation to LX1004 for the treatment of CLN2 Batten disease.
    [LEXEO Therapeutics]

    Press Release
    FEATURED EVENT

    Frontiers in Cancer Science 2022

    November 7 – 9, 2022
    Singapore, Singapore

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Neuroscience

    Salk Institute for Biological Studies – San Diego, California, United States

    Assistant Professor – Cellular and Molecular Neuroscience

    Colgate University – Hamilton, New York, United States

    Advanced Research Assistant – Artificial Intelligence in Cancer Evolution and Genomics

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    Tenure Track Assistant Professor – Developmental Neurobiology

    Virginia Tech – Roanoke, Virginia, United States

    Postdoctoral – Neural Circuits and Cellular Neurophysiology

    Laval University – Quebec City, Quebec, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter